Tannin-based antiproliferative pharmaceutical
US-2024293492-A1 · Sep 5, 2024 · US
US10195241B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10195241-B2 |
| Application number | US-201615192514-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 24, 2016 |
| Priority date | Jun 26, 2015 |
| Publication date | Feb 5, 2019 |
| Grant date | Feb 5, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This disclosure relates to extracts from chestnut plants and compositions comprising compounds contained therein. In certain embodiments, the extracts are derived from the leaves of a Castanea plant. In certain embodiments, the disclosure relates to methods of treating or preventing bacterial infections, acne, and other related uses.
Opening claim text (preview).
The invention claimed is: 1. A wound dressing or wound rinse comprising compounds in an extract, wherein the wound dress comprises an absorbent pad and optionally an adhesive, and wherein the extract comprises a leaf derived mixture of compounds from a Castanea plant wherein the extracting process comprises the steps of: mixing a leaf with methanol under conditions such that leaf compounds dissolves in the methanol and removing the methanol providing a methanol derived mixture of compounds, partitioning the methanol derived mixture of compounds in hexane and water providing a water derived mixture of compounds, partitioning the water derived mixture of compounds by mixing the water with ethyl acetate under conditions such that leaf compounds dissolve in the ethyl acetate and removing the ethyl acetate providing an ethyl acetate derived mixture of compounds; and purifying the ethyl acetate derived mixture of compounds by liquid chromatography through silica with a mobile phase comprising hexane and ethyl acetate; wherein the mobile phase comprises increasing amounts of ethyl acetate, and a mobile phase fraction is isolated comprising a leaf derived mixture of compounds which does not contain chlorogenic acid, ellagic acid, hyperoside, isoquercitrin or rutin. 2. The extract of claim 1 , wherein the mixture of compounds comprises components having the following formulas and relative abundance, C 39 H 59 O 8 or C 38 H 55 O 9 , or mixture, with a relative abundance of 0.1 to 0.9%; C 35 H 59 O 6 with a relative abundance of 0.1 to 0.9%; C 31 H 49 O 6 with a relative abundance of 1.0 to 2.0%; C 32 H 51 O 7 with a relative abundance of 0.1 to 0.9%; C 30 H 48 O 5 with a relative abundance of 3.0 to 5.0%; C 30 H 48 O 6 with a relative abundance of 6.0 to 8.0%; and C 30 H 45 O 5 with a relative abundance of 2.0 to 4.0%. 3. The extract of claim 2 , further comprises additional components of different compounds having the following formula and relative abundance, C 35 H 59 O 6 with a relative abundance of 0.2 to 0.4; C 27 H 23 O 18 is with a relative abundance of 0.05 to 0.30; C 39 H 31 O 15 with a relative abundance of 0.50 to 0.80; C 17 H 11 O 8 or C 20 H 11 O 4 N 2 , or mixture, with a relative abundance of 0.5 to 1.0; and C 34 H 29 O 15 with a relative abundance of 0.2 to 0.4%.
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Fagaceae (Beech family), e.g. oak or chestnut · CPC title
Washing or bathing preparations · CPC title
Medicaments · CPC title
involving mechanical treatment, e.g. chopping up, cutting or grinding · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.